AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Teaching an Old Drug New Tricks: Leprosy Medicine Holds Promise as Therapy for Autoimmune Diseases.

Europe Intelligence Wire

| January 30, 2009 | COPYRIGHT 2003 Financial Times Ltd. (Hide copyright information)Copyright

(From AScribe)

BALTIMORE -- A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an antileprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases.

"We never expected that an old antibiotic would hit this target that has been implicated in multiple sclerosis, psoriasis and type 1 diabetes," says Johns Hopkins pharmacologist Jun O. Liu "People have been working for years and spending tens of millions of dollars on developing a drug to inhibit a specific molecular target involved in these diseases, and here, we have a safe, known drug that hits that target," known as the Kv1.3 potassium channel. …

Related articles from newspapers, magazines, journals, and more
Johns Hopkins Team Finds New Way to Attack TB.
News wire article from: Europe Intelligence Wire March 24, 2010 700+ words
New Hope for Cancer Comes Straight From the Heart; Johns Hopkins Researchers...
News wire article from: Europe Intelligence Wire January 5, 2009 700+ words
Johns Hopkins Study Reveals White Blood Cells Can Both Hurt and Help...
News wire article from: Europe Intelligence Wire September 20, 2006 700+ words
Up a Little on the Left ... Now, Over to the Right ... Johns Hopkins...
News wire article from: Europe Intelligence Wire December 21, 2009 700+ words
Understanding Night Blindness and Calcium: Johns Hopkins Researchers Uncover...
News wire article from: Europe Intelligence Wire March 30, 2010 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily